449 related articles for article (PubMed ID: 26645869)
1. Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease?
Peck AB; Canales BK; Nguyen CQ
Urolithiasis; 2016 Feb; 44(1):45-50. PubMed ID: 26645869
[TBL] [Abstract][Full Text] [Related]
2. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study.
Tavasoli S; Alebouyeh M; Naji M; Shakiba Majd G; Shabani Nashtaei M; Broumandnia N; Basiri A
BJU Int; 2020 Jan; 125(1):133-143. PubMed ID: 31145528
[TBL] [Abstract][Full Text] [Related]
3. Role of gut microbiota against calcium oxalate.
Sadaf H; Raza SI; Hassan SW
Microb Pathog; 2017 Aug; 109():287-291. PubMed ID: 28624518
[TBL] [Abstract][Full Text] [Related]
4. Cloning and expression of the oxalyl-CoA decarboxylase gene from the bacterium, Oxalobacter formigenes: prospects for gene therapy to control Ca-oxalate kidney stone formation.
Lung HY; Cornelius JG; Peck AB
Am J Kidney Dis; 1991 Apr; 17(4):381-5. PubMed ID: 2008903
[TBL] [Abstract][Full Text] [Related]
5. Oxalate-degrading bacteria of the human gut as probiotics in the management of kidney stone disease.
Abratt VR; Reid SJ
Adv Appl Microbiol; 2010; 72():63-87. PubMed ID: 20602988
[TBL] [Abstract][Full Text] [Related]
6. The role of the microbiome in kidney stone formation.
Mehta M; Goldfarb DS; Nazzal L
Int J Surg; 2016 Dec; 36(Pt D):607-612. PubMed ID: 27847292
[TBL] [Abstract][Full Text] [Related]
7. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.
Sidhu H; Schmidt ME; Cornelius JG; Thamilselvan S; Khan SR; Hesse A; Peck AB
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S334-40. PubMed ID: 10541258
[TBL] [Abstract][Full Text] [Related]
8. [Oxalobacter formigenes--characteristics and role in development of calcium oxalate urolithiasis].
Torzewska A
Postepy Hig Med Dosw (Online); 2013 Nov; 67():1144-53. PubMed ID: 24379255
[TBL] [Abstract][Full Text] [Related]
9. Presence of Oxalobacter formigenes in the intestinal tract is associated with the absence of calcium oxalate urolith formation in dogs.
Gnanandarajah JS; Abrahante JE; Lulich JP; Murtaugh MP
Urol Res; 2012 Oct; 40(5):467-73. PubMed ID: 22223029
[TBL] [Abstract][Full Text] [Related]
10. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease.
Siva S; Barrack ER; Reddy GP; Thamilselvan V; Thamilselvan S; Menon M; Bhandari M
BJU Int; 2009 Jan; 103(1):18-21. PubMed ID: 19021605
[TBL] [Abstract][Full Text] [Related]
11. Designer probiotic Lactobacillus plantarum expressing oxalate decarboxylase developed using group II intron degrades intestinal oxalate in hyperoxaluric rats.
Paul E; Albert A; Ponnusamy S; Mishra SR; Vignesh AG; Sivakumar SM; Sivasamy G; Sadasivam SG
Microbiol Res; 2018 Oct; 215():65-75. PubMed ID: 30172310
[TBL] [Abstract][Full Text] [Related]
12. Contribution of Dietary Oxalate and Oxalate Precursors to Urinary Oxalate Excretion.
Crivelli JJ; Mitchell T; Knight J; Wood KD; Assimos DG; Holmes RP; Fargue S
Nutrients; 2020 Dec; 13(1):. PubMed ID: 33379176
[TBL] [Abstract][Full Text] [Related]
13. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
Troxel SA; Sidhu H; Kaul P; Low RK
J Endourol; 2003 Apr; 17(3):173-6. PubMed ID: 12803990
[TBL] [Abstract][Full Text] [Related]
14. Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria?
Hoppe B; von Unruh G; Laube N; Hesse A; Sidhu H
Urol Res; 2005 Nov; 33(5):372-5. PubMed ID: 16284877
[TBL] [Abstract][Full Text] [Related]
15. Analysis of commercial kidney stone probiotic supplements.
Ellis ML; Shaw KJ; Jackson SB; Daniel SL; Knight J
Urology; 2015 Mar; 85(3):517-21. PubMed ID: 25733259
[TBL] [Abstract][Full Text] [Related]
16. Oxalobacter formigenes: A new hope as a live biotherapeutic agent in the management of calcium oxalate renal stones.
Hiremath S; Viswanathan P
Anaerobe; 2022 Jun; 75():102572. PubMed ID: 35443224
[TBL] [Abstract][Full Text] [Related]
17. Forty Years of Oxalobacter formigenes, a Gutsy Oxalate-Degrading Specialist.
Daniel SL; Moradi L; Paiste H; Wood KD; Assimos DG; Holmes RP; Nazzal L; Hatch M; Knight J
Appl Environ Microbiol; 2021 Aug; 87(18):e0054421. PubMed ID: 34190610
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis.
Miller AW; Choy D; Penniston KL; Lange D
Kidney Int; 2019 Jul; 96(1):180-188. PubMed ID: 31130222
[TBL] [Abstract][Full Text] [Related]
19. Stable expression of the oxc and frc genes from Oxalobacter formigenes in human embryo kidney 293 cells: implications for gene therapy of hyperoxaluria.
Ye ZQ; Kong DB; Chen ZQ; Yao LF; Guo H; Yu X; Liu GL; Yang WM
Int J Mol Med; 2007 Oct; 20(4):521-6. PubMed ID: 17786282
[TBL] [Abstract][Full Text] [Related]
20. The management of patients with enteric hyperoxaluria.
Asplin JR
Urolithiasis; 2016 Feb; 44(1):33-43. PubMed ID: 26645872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
